Clinical Trials on 非转移性浸润性乳腺癌 in Hong Kong
总计492个结果
-
Chinese University of Hong KongDepartment of Electronic and computer engineering, HKUST; Department of clinical oncology, CUHK 和其他合作者招聘中
-
Chinese University of Hong KongPrincess Margaret Hospital, Hong Kong招聘中
-
Organisation for Oncology and Translational Research未知
-
The University of Hong Kong未知
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong; Queen Mary Hospital... 和其他合作者主动，不招人
-
The Hong Kong Polytechnic UniversityQueen Elizabeth Hospital, Hong Kong完全的
-
Dr Joanne CHIU招聘中ALK基因重排阳性 | EGF-R阳性非小细胞肺癌 | EGFR激活突变 | NSCLC | ROS1基因重排 | ROS1 阳性 NSCLC - 活性氧 1 阳性非小细胞肺癌香港
-
National Cancer Institute (NCI)Chinese University of Hong Kong完全的
-
The University of Hong KongResearch Grants Council, Hong Kong招聘中
-
Nam Dinh University of NursingThe Hong Kong Polytechnic University完全的
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany完全的
-
The University of Hong KongFood and Health Bureau, Hong Kong Government主动，不招人
-
Chinese University of Hong Kong完全的
-
Hong Kong Children's HospitalThe University of Hong Kong招聘中
-
Shanghai Pulmonary Hospital, Shanghai, ChinaThe University of Hong Kong尚未招聘
-
Chinese University of Hong Kong招聘中
-
The University of Hong KongChinese University of Hong Kong完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.招聘中
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales Servier尚未招聘
-
Novartis Pharmaceuticals完全的具有高 TAM 的晚期三阴性乳腺癌 (TNBC)法国, 意大利, 奥地利, 台湾, 美国, 西班牙, 澳大利亚, 大韩民国, 比利时, 德国, 香港, 火鸡
-
National Cancer Centre, SingaporePfizer主动，不招人NSCLC IV期 | 非小细胞肺癌 IIIB 期 | 复发性非小细胞肺癌 | NSCLC IIIC 期 | EGFR阳性非小细胞肺癌大韩民国, 香港, 泰国, 新加坡, 马来西亚
-
National Cancer Center, Korea完全的
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)完全的
-
National Cancer Centre, SingaporeSingapore General Hospital招聘中